We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$712B
AUM Growth
+$77.7B
Cap. Flow
+$20.3B
Cap. Flow %
2.85%
Top 10 Hldgs %
29.74%
Holding
13,792
New
1,607
Increased
5,174
Reduced
5,388
Closed
1,330

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$2.51B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.53B
3
AMZN icon
Amazon
AMZN
+$1.11B
4
ABNB icon
Airbnb
ABNB
+$574M
5
NVDA icon
NVIDIA
NVDA
+$519M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 1.94%
2 Technology 1.9%
3 Communication Services 1.42%
4 Financials 1.08%
5 Healthcare 0.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NERV icon
11976
Minerva Neurosciences
NERV
$244M
$107K ﹤0.01%
5,788
+2,792
+93% +$60.1K
TISI icon
11977
PUT
Team
TISI
$107M
$107K ﹤0.01%
+1,590
New +$145K
NSTB
11978
CALL
DELISTED
Northern Star Investment Corp. II
NSTB
$107K ﹤0.01%
+10,700
New +$107K
EMAN
11979
PUT
DELISTED
eMagin Corporation
EMAN
$107K ﹤0.01%
30,800
-79,000
-72% -$244K
ACGN
11980
CALL
DELISTED
Aceragen Inc
ACGN
$107K ﹤0.01%
5,235
+719
+16% +$14.5K
AEG icon
11981
PUT
Aegon
AEG
$13.7B
$106K ﹤0.01%
27,388
-13,578
-33% -$57.8K
ATXS
11982
DELISTED
Astria Therapeutics
ATXS
$106K ﹤0.01%
8,379
-12,722
-60% -$165K
ITP icon
11983
CALL
IT Tech Packaging
ITP
$3.1M
$106K ﹤0.01%
22,540
-14,790
-40% -$75.8K
TALK
11984
DELISTED
Talkspace
TALK
$106K ﹤0.01%
12,780
-5,228
-29% -$50.8K
QUMU
11985
PUT
DELISTED
Qumu Corp.
QUMU
$106K ﹤0.01%
+36,800
New +$181K
OTIC
11986
PUT
DELISTED
Otonomy, Inc.
OTIC
$106K ﹤0.01%
47,600
-13,200
-22% -$30.5K
SVA
11987
DELISTED
Sinovac Biotech, Ltd
SVA
$106K ﹤0.01%
16,430
CTXR icon
11988
PUT
Citius Pharmaceuticals
CTXR
$16.3M
$105K ﹤0.01%
+1,212
New +$72.8K
FENC icon
11989
Fennec Pharmaceuticals
FENC
$403M
$105K ﹤0.01%
+14,398
New +$96.1K
IIAC
11990
DELISTED
Investindustrial Acquisition Corp.
IIAC
$105K ﹤0.01%
10,799
+376
+4% +$3.7K
AQST icon
11991
CALL
Aquestive Therapeutics
AQST
$646M
$104K ﹤0.01%
26,200
-17,900
-41% -$71.5K
PXLW icon
11992
PUT
Pixelworks
PXLW
$42.8M
$104K ﹤0.01%
2,550
+117
+5% +$4.59K
CTG
11993
DELISTED
Computer Task Group, Inc.
CTG
$104K ﹤0.01%
10,765
-392
-4% -$3.94K
REED
11994
CALL
DELISTED
Reeds, Inc. Common Stock
REED
$104K ﹤0.01%
2,036
+1,380
+210% +$70.9K
LHAA
11995
DELISTED
Lerer Hippeau Acquisition Corp. Class A Common Stock
LHAA
$104K ﹤0.01%
10,567
-400
-4% -$3.97K
HIGA.U
11996
DELISTED
H.I.G. Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
HIGA.U
$104K ﹤0.01%
+10,383
New +$105K
GWH icon
11997
ESS Tech
GWH
$14.8M
$103K ﹤0.01%
693
-299
-30% -$44.3K
CD
11998
Chaince Digital Holdings
CD
$358M
$103K ﹤0.01%
+17,992
New +$122K
OPTT icon
11999
CALL
Ocean Power Technologies
OPTT
$45.8M
$103K ﹤0.01%
41,000
-9,700
-19% -$24K
USIO icon
12000
CALL
Usio Inc
USIO
$84.3M
$103K ﹤0.01%
+16,100
New +$100K

Similar funds

Jeff Yass's Q2 2021 Portfolio in Review

As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 1.9% of assets, up from 1.7% a quarter earlier, followed by Technology and Communication Services.

  • Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
  • Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
  • Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
  • Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
  • Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
  • Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
  • Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.

Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.